---
layout: post
title: "Clee Medical wins CHF 150,000 to develop next-generation neurosurgical technology."
date: 2025-03-01
background: '/img/posts/alanthealth.jpg'
---

<div class="mb-4">
  <h3 class="font-weight-bold">Wyss Center for Bio and Neuroengineering</h3>
  <p class="font-italic">Innovate. Accelerate. Transform lives.</p>
</div>

<p>ğŸŒŸWe are excited to announce that one of our spin-offs, Clee Medical SA, has won the third stage of the Venture Kick programâ€”an initiative that supports the development of high-potential businesses in Switzerland! ğŸ‰ The start-up has secured CHF 150,000 to further its groundbreaking neurosurgical technology.</p>

<p>By combining advanced imaging with AI-assisted guidance, Clee Medical is addressing key challenges in neurosurgeryâ€”enhancing visualization, reducing surgical risks, and expanding treatment possibilities. Their innovative technology seamlessly integrates into existing workflows, offering 300,000 more voxels per unit volume than MRIâ€”without contrast agents or radiation.</p>

<p>ğŸ‘ We are thrilled to see CleeMedical's work recognized for bringing next-generation technology to neurosurgeons, advancing precision, and ultimately improving patient outcomes.</p>

<p>Check out our latest update on LinkedIn:</p>
<iframe src="https://www.linkedin.com/embed/feed/update/urn:li:share:7310962789127278593" height="800" width="600" frameborder="0" allowfullscreen="" title="Embedded post"></iframe>
